Health and Global Policy Institute (HGPI) released recommendations for the G7 Hiroshima Summit entitled, “The Political Leadership and International Collaboration Needed to Advance Antimicrobial Resistance (AMR) Countermeasures.”

[Summary]

Recommendation 1: Continue providing the political leadership needed to combat AMR.
Recommendation 2: Establish opportunities to examine AMR countermeasures at discussions that span multiple fields like the Joint Conference of Foreign Ministers and Health Ministers.

Antimicrobial resistance (AMR) has been continuously recognized as a public health threat of greatest concern both in Japan and abroad, and concentrated efforts from various related parties around the world have resulted in steady progress in measures to combat AMR. In recent years, the G7 has recognized that achieving comprehensive innovation in all areas of prevention, diagnosis, and treatment will be crucial for pandemic prevention, preparedness, and response (PPR).
As we enter the post-COVID-19 era, we must not overlook the role of antimicrobials as global public goods if we wish to continue enjoying peace, stability, and prosperity.
As discussions on international agreements regarding infectious diseases like the International Health Regulation (IHR) and the Pandemic Treaty continue to advance, it will be important to promote AMR countermeasures based on the concept of One Health, in which the health of humans, animals, and the environment are viewed as one. To this end, opportunities for discussions that cut across fields and advocate for that approach should be established at G7 Summits and other high-level meetings. Consideration of financial resource mobilization is also required. As the next G7 President in 2023, it will be crucial for Japan to fulfill its commitments to the international community based on the fact that infectious disease control cannot be fully implemented by countries acting alone and that each country’s interests are adjacent to those of the entire world.

For further details, please see the end of the PDF.